載入...
Targeting Disseminated Estrogen-Receptor-Positive Breast Cancer Cells in Bone Marrow
Estrogen receptor-positive (ER+) breast cancer can recur up to 20 years after initial diagnosis. Delayed recurrences arise from disseminated tumors cells (DTCs) in sites such as bone marrow that remain quiescent during endocrine therapy and subsequently proliferate to produce clinically-detectable m...
Na minha lista:
| 發表在: | Oncogene |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7442734/ https://ncbi.nlm.nih.gov/pubmed/32678295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01391-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|